Clinical trials
Out-of-Hospital Cardiac Arrest trials in the United Kingdom with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barts & The London NHS Trust | 2 |
| Australian and New Zealand Intensive Care Research Centre | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| Helsingborgs Hospital | 1 |
| Helsinki University Central Hospital | 1 |
| Mid and South Essex NHS Foundation Trust | 1 |
| Niklas Nielsen | 1 |
| Queen Mary University of London | 1 |
| Region Skane | 1 |
| University Hospital Southampton NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Out-of-Hospital Cardiac Arrest | 12 |
| Heart Arrest | 8 |
| Ventricular Fibrillation | 2 |
| Acute Kidney Injury | 1 |
| Arrhythmias, Cardiac | 1 |
| Brain Injuries | 1 |
| Cardiovascular Diseases | 1 |
| Cognition Disorders | 1 |
| Coma | 1 |
| Death, Sudden, Cardiac | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.